Literature DB >> 33165979

RNF170-Related Hereditary Spastic Paraplegia: Confirmation by a Novel Mutation.

Jean-Madeleine de Sainte Agathe1, Sandra Mercier2,3, Jean-Yves Mahé3,4, Yann Péréon3,5, Julien Buratti1, Laurène Tissier1, Bophara Kol1, Samia Ait Said1, Éric Leguern1,6, Guillaume Banneau1, Giovanni Stévanin6,7.   

Abstract

BACKGROUND: Spastic paraparesis and biallelic variants functionally characterized as deleterious in the RNF170 gene have recently been reported by Wagner et al. 2019, strongly supporting the involvement of this gene in hereditary spastic paraplegia.
METHODS: Exome sequencing was performed on 6 hereditary spastic paraplegia families previously tested on an hereditary spastic paraplegia-specific panel.
RESULTS: We describe here a novel hereditary spastic paraplegia family with 4 affected members carrying a homozygous p.(Tyr114*) stop gain variant in RNF170.
CONCLUSIONS: We confirm the involvement of biallelic truncating variants in RNF170 in a novel form of hereditary spastic paraplegia.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  RNF170; ataxia; biallelic loss of function; hereditary spastic paraplegia

Mesh:

Substances:

Year:  2020        PMID: 33165979     DOI: 10.1002/mds.28371

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  2 in total

1.  RNF170 mutation causes autosomal dominant sensory ataxia with variable pyramidal involvement.

Authors:  Sien H Van Daele; Matthieu Moisse; Valérie Race; Amélie Van Eesbeeck; Liesbeth Keldermans; Sascha Vermeer; Hilde Van Esch; Kristl G Claeys; Philip Van Damme
Journal:  Eur J Neurol       Date:  2021-09-17       Impact factor: 6.288

Review 2.  Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia.

Authors:  Lydia Saputra; Kishore Raj Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-28       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.